HY-100182-1mg
|
MedChemexpress LLC
|
BACE1-IN-1 [CAS 1310347-50-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100182-10mg
|
MedChemexpress LLC
|
BACE1-IN-1 [CAS 1310347-50-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100182-100mg
|
MedChemexpress LLC
|
BACE1-IN-1 [CAS 1310347-50-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100182-25mg
|
MedChemexpress LLC
|
BACE1-IN-1 [CAS 1310347-50-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100182-5mg
|
MedChemexpress LLC
|
BACE1-IN-1 [CAS 1310347-50-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100182-50mg
|
MedChemexpress LLC
|
BACE1-IN-1 [CAS 1310347-50-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100275-1mg
|
MedChemexpress LLC
|
MK-3328 [CAS 1201323-97-8]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100347A-10mg
|
MedChemexpress LLC
|
SRI-011381 (hydrochloride) [CAS 2070014-88-7]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100347A-100mg
|
MedChemexpress LLC
|
SRI-011381 (hydrochloride) [CAS 2070014-88-7]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100347A-25mg
|
MedChemexpress LLC
|
SRI-011381 (hydrochloride) [CAS 2070014-88-7]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100347A-5mg
|
MedChemexpress LLC
|
SRI-011381 (hydrochloride) [CAS 2070014-88-7]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100347A-50mg
|
MedChemexpress LLC
|
SRI-011381 (hydrochloride) [CAS 2070014-88-7]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100411-10mg
|
MedChemexpress LLC
|
MLi-2 [CAS 1627091-47-7]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100411-100mg
|
MedChemexpress LLC
|
MLi-2 [CAS 1627091-47-7]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100411-5mg
|
MedChemexpress LLC
|
MLi-2 [CAS 1627091-47-7]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100411-50mg
|
MedChemexpress LLC
|
MLi-2 [CAS 1627091-47-7]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100547-10mg
|
MedChemexpress LLC
|
IEM-1754 [CAS 162831-31-4]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100547-25mg
|
MedChemexpress LLC
|
IEM-1754 [CAS 162831-31-4]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100547-5mg
|
MedChemexpress LLC
|
IEM-1754 [CAS 162831-31-4]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100547-50mg
|
MedChemexpress LLC
|
IEM-1754 [CAS 162831-31-4]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100549-10mg
|
MedChemexpress LLC
|
(S)-Crizotinib [CAS 1374356-45-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100549-100mg
|
MedChemexpress LLC
|
(S)-Crizotinib [CAS 1374356-45-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100549-5mg
|
MedChemexpress LLC
|
(S)-Crizotinib [CAS 1374356-45-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100549-50mg
|
MedChemexpress LLC
|
(S)-Crizotinib [CAS 1374356-45-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100550-10mg
|
MedChemexpress LLC
|
MSDC 0160 [CAS 146062-49-9]
|
|
Neuroscience-Neurodegeneration
|
|